Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday ...

Key Insights Institutions' substantial holdings in Cardinal Health implies that they have significant influence ...

U.S. stock futures are down, with earnings from Cardinal Health Inc. and Sea Ltd. to watch. ZipRecruiter Inc. beats ...

Approximately six in 10 U.S. adults reported taking a prescription drug, and a quarter of U.S. adults take four or more.

Cardinal Health is likely to purchase its majority stake in GIA for approximately $2.8 billion in cash, which will represent 71% ownership. Meanwhile, ADSG is set to be acquired by CAH for ...

Cardinal Health Inc. is exploring a potential sale of its nuclear medicine business as part of a larger review of its strategy and operations, according to people familiar with the matter.

On an adjusted basis, Cardinal Health now expects to earn in the range of $5.60 to $5.80 per share in 2023, compared with its prior forecast range of $5.20 to $5.50 per share. Analysts on average ...

Cardinal Health is one of Ohio's largest companies by revenue, but because its drug-distribution and medical-products businesses serve mainly health-industry customers, many consumers do not know ...

Holcomb: At Cardinal Health, innovation and inclusion are two of our five values. When we proactively incorporate diversity, we see an increase in the amount of creativity and innovation that's ...